Table 2.
Description | Summary | PZ | TZ | CZ |
---|---|---|---|---|
Patients (N) | 102 | |||
Age (yr.) | 64 (44–84) | |||
PSA (ng/mL) | 5.95 (1.17–113.6) | |||
Prostate Volume (mL) | 51.5 (19–100) | |||
Lesions (n) | 205 | 155 | 49 | 1 |
Benign | 121 | 91 | 30 | 0 |
GS 3+3 | 29 | 23 | 6 | 0 |
GS 3+4 | 29 | 24 | 5 | 0 |
GS 4+3 | 10 | 7 | 3 | 0 |
GS 4+4 | 11 | 7 | 3 | 1 |
GS> 4+4 | 5 | 3 | 2 | 0 |
Note.- Median values with ranges reported in parentheses. PSA = prostate-specificantigen, PZ = peripheral zone, TZ = transition zone, GS =Gleason score.